KCAS Bioanalytical Acquires FlowMetric, LLC

KCAS Acquires France-based Active Biomarkers

September 12, 2022

Healthcare Services

KCAS Bioanalytical and Biomarker Services, a Vitruvian Partners-backed CRO headquartered in Olathe, Kansas, has acquired Active Biomarkers, a bioanalytical laboratory based in Lyon, France. The deal, previously owned by the management team and Turenne Santé, expands KCAS's European footprint and adds specialty bioassay and cellular analysis capabilities to support pharma and biotech customers worldwide.

SPL Inc. Acquires Volumetrics

September 11, 2023

Industrial Services

SPL Inc., a Sentinel Capital Partners–backed provider of testing, inspection and calibration services, has acquired Volumetrics, a specialist in flow meter verification and fiscal loss mitigation. The deal expands SPL’s mobile flow laboratory footprint across North Dakota, Wyoming, Colorado, Texas and New Mexico and adds metrology and data capabilities to its Metrology Division.

Saint-Gobain Life Sciences Acquires Equflow B.V.

September 2, 2021

Medical Devices

Saint-Gobain Life Sciences has acquired Equflow B.V., a Netherlands-based designer and manufacturer of flowmeters and sensors serving the single-use bioprocessing market. The acquisition expands Saint-Gobain's Bio-Process Solutions product capabilities and single-use fluid management offerings.

Precision Cell Systems Acquires BennuBio

October 1, 2025

Biotechnology

Precision Cell Systems (PCS) has acquired BennuBio, a New Mexico–based developer of the Velocyt imaging flow cytometer, to expand PCS's single-cell and 3D cell culture analysis capabilities. BennuBio founders and leadership will join PCS to integrate the Velocyt platform, and BennuBio lead investor Tramway Ventures has joined PCS's investor syndicate to support the company's consolidation strategy.

BioAgilytix Acquires Cambridge Biomedical

November 4, 2019

Healthcare Services

BioAgilytix, a GHO Capital portfolio company, has acquired Cambridge Biomedical, a Cambridge, Massachusetts–based clinical research organisation specializing in large-molecule bioanalysis. The deal expands BioAgilytix's laboratory capacity and capabilities (including CLIA/CAP/GLP capabilities and PCR/molecular suites), broadens its geographic footprint into the Boston/Cambridge biotech cluster, and strengthens its cell- and gene-therapy bioanalytical offerings.

Bruker Corporation Acquires Canopy Biosciences, LLC

September 11, 2020

Biotechnology

Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.